Aducanumab (BIIB037) for Early Alzheimer's Disease

Language
Undefined

Purpose: To evaluate treatment of early Alzheimer's disease with the experimental drug aducanumab (BIIB037).

Source: Alzheimers Clinical Trials - July 27, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials